---
audienceLevel: patient
cancerTypes:
- colorectal
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: XELOX - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/xelox
version: v1
---

# XELOX - NCI

# XELOX

Placeholder slot

This chemotherapy combination contains the drugs capecitabine (Xeloda) and oxaliplatin. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the XELOX combination:

|  |  |
| --- | --- |
| **XEL** | = [Capecitabine](/about-cancer/treatment/drugs/capecitabine) (Xeloda) |
| **OX** | = [Oxaliplatin](/about-cancer/treatment/drugs/oxaliplatin) |

Each of the drugs in this combination is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to cancer.

## Use in Cancer

XELOX
is used to treat:

- **[Colorectal cancer](/Common/PopUps/popDefinition.aspx?id=444983&version=Patient&language=English)** that is [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English).

This combination may also be used with other drugs or treatments or to treat other types of cancer.

## More About XELOX

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/657267) - Detailed scientific definition and other names for this drug.
